Last updated: April 23, 2026
Who Supplies Diphenhydramine Hydrochloride and Naproxen Sodium?
What counts as a “supplier” in pharma?
For diphenhydramine hydrochloride and naproxen sodium, “supplier” can mean:
- API manufacturers (make the drug substance)
- intermediates/synthetic route suppliers (feedstock for API)
- drug product manufacturers (formulation and finishing, when API supply is sourced upstream)
- distributors / contract suppliers (sell API sourced from one or more underlying manufacturers)
Without a defined scope (API vs finished dosage, geography, grade, and regulatory status), the supplier set can vary materially. Given only the active ingredients, the most decision-relevant target is API suppliers capable of supplying pharmaceutical-grade materials used in commercial dosage forms.
Diphenhydramine hydrochloride: supplier landscape (API)
Diphenhydramine hydrochloride is a widely used first-generation antihistamine with broad manufacturing coverage across multiple regions. Common upstream sourcing channels include:
- Large-scale generic API producers (multiple plants; DMFs or CEPs depending on market)
- Specialty pharma chemical manufacturers (often with fewer plants but frequent batch exports)
- China-based API producers supplying global distributors
Typical supplier categories for diphenhydramine hydrochloride
- API manufacturers supplying pharmaceutical-grade diphenhydramine hydrochloride (anhydrous or specified hydrate form as applicable)
- API intermediates suppliers for core synthesis steps (e.g., diarylethylamine and ether-forming intermediates depending on route)
- Distributors selling branded and non-branded API lots into North America and Europe
Procurement-relevant spec points suppliers must match
Even when suppliers are plentiful, buyers typically screen suppliers on:
- Assay and impurities (impurity profile consistency matters for ANDA/DMF dossiers)
- Residual solvents
- Solvent/water content and solid-state form
- Particle size (if relevant to downstream tablet/capsule dissolution)
- Regulatory documentation (DMF status, CEP, GMP certificate by site)
Naproxen sodium: supplier landscape (API)
Naproxen sodium is a non-steroidal anti-inflammatory drug active used in tablets and gel formulations. As with diphenhydramine hydrochloride, supplier coverage is broad globally.
Typical supplier categories for naproxen sodium
- API manufacturers producing naproxen sodium salt form
- Producers of naproxen acid feeding salt formation (sodium neutralization and isolation control)
- Distributors exporting naproxen sodium API in bulk lots
- Contract manufacturers producing finished dosage products under license, when buyers are not sourcing API directly
Procurement-relevant spec points suppliers must match
For naproxen sodium, buyers commonly validate:
- Salt identity and stoichiometry (sodium salt form)
- Impurity profile (including related substances from acid/salt conversion)
- Crystal form behavior and stability under storage
- Moisture and residual solvents
- Particle size distribution
- Regulatory status and batch traceability
What buyers usually do to select suppliers
To avoid supply-chain and compliance failures, pharmaceutical buyers typically run a structured supplier qualification that includes:
- Documentation: DMF/CEP availability for the intended market
- GMP: certificate covering the specific API manufacturing site
- Quality: COA comparability (assay, impurities, solvents)
- Technical: particle size, polymorph/crystal behavior (as applicable)
- Supply: lead times, batch size capability, change-control history
Key Takeaways
- Both diphenhydramine hydrochloride and naproxen sodium have broad global API manufacturing coverage, making supplier selection mostly a qualification and regulatory fit problem, not a scarcity problem.
- The most decision-relevant “suppliers” are API manufacturing sites with market-appropriate regulatory documentation (DMF/CEP) and validated specs for impurities, solvents, solid-state form, and salt identity.
- Buyers typically screen on site-level GMP, COA consistency, and impurity/salt-form controls, then lock in through qualification and contractual quality agreements.
FAQs
1) Are there many API suppliers for diphenhydramine hydrochloride?
Yes. Diphenhydramine hydrochloride is an established generic active ingredient with multiple worldwide API manufacturing sources.
2) Do suppliers of naproxen sodium also supply naproxen acid?
Many do, because naproxen sodium is commonly produced by converting naproxen acid to the sodium salt form under controlled conditions.
3) What matters more than “price” when choosing an API supplier?
Regulatory documentation (DMF/CEP where applicable), site GMP, and reproducible quality (impurities, residual solvents, and form control) drive approval and downstream batch acceptance.
4) Can distributors be treated as “suppliers” for compliance purposes?
Distributors can provide the material, but compliance rests on the underlying manufacturing site and its quality system. Buyers should qualify the manufacturing source, not only the distributor.
5) Does solid form matter for both actives?
Yes. Diphenhydramine hydrochloride solid-state and naproxen sodium salt identity and crystal behavior can affect stability, impurities, and downstream performance.
